Showing results (341-350 of 392) with videos related to

Sort By:
Pageof 40
Molecular Cancer Research : MCR|January 14, 2021
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other OrgansAnna S Berghoff, Yunxiang Liao, Matthia A Karreman, et al.
Cell Stem Cell|May 8, 2026
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AMLAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Research Square|June 22, 2026
Nociceptor neurons suppress antitumor immunity in breast cancerSebastien Talbot, Yue Wu, Maryam Ahmadi, et al.
Canadian Journal of Kidney Health and Disease|December 14, 2018
An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study)Steven Soroka, Mohsen Agharazii, Sandra Donnelly, et al.
The Journal of Clinical Investigation|May 16, 2019
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cellsDarja Karpova, Michael P Rettig, Julie Ritchey, et al.
Nature|August 3, 2018
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Nature Methods|August 7, 2025
Ultra-high-scale cytometry-based cellular interaction mappingDominik Vonficht, Lea Jopp-Saile, Schayan Yousefian, et al.
Cell Stem Cell|April 25, 2023
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemiaSergi Beneyto-Calabuig, Anne Kathrin Merbach, Jonas-Alexander Kniffka, et al.
Cancer Research|November 11, 2025
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 InactivationVincent Rondeau, Suraj Bansal, Marco M Buttigieg, et al.
Molecular Cancer|May 9, 2024
Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cellsLisa-Marie Rieckmann, Michael Spohn, Lisa Ruff, et al.
Pageof 40